T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 | +$1.66B | |
| 2 | +$1.39B | |
| 3 | +$1.38B | |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| 1 | +$4.2B | |
| 2 | +$3.24B | |
| 3 | +$2.75B | |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| 1 | Technology | 35.67% |
| 2 | Financials | 11.77% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Skyworks Solutions
SWKS
$8.36B
| $13.6M | ﹤0.01% |
215,099
+1,846
|
|
||
1152
Arcosa
ACA
$5.3B
| $13.6M | ﹤0.01% |
128,197
+81,103
|
|
||
1153
Berkshire Hathaway Class A
BRK.A
$1.06T
| $13.6M | ﹤0.01% |
18
|
|
||
1154
Check Point Software Technologies
CHKP
$16.7B
| $13.6M | ﹤0.01% |
73,169
+3,583
|
|
||
|
HSAI
1155
Hesai Group
HSAI
$3.87B
| $13.6M | ﹤0.01% |
606,060
|
|
||
1156
Hancock Whitney
HWC
$5.05B
| $13.5M | ﹤0.01% |
212,214
+16,153
|
|
||
1157
Hamilton Lane
HLNE
$4.09B
| $13.5M | ﹤0.01% |
100,379
+53,987
|
|
||
1158
Rivian
RIVN
$19.8B
| $13.4M | ﹤0.01% |
682,012
+38,177
|
|
||
|
ZBIO
1159
Zenas BioPharma
ZBIO
$1.33B
| $13.4M | ﹤0.01% |
369,248
-5,050
|
|
||
1160
Rithm Capital
RITM
$5.43B
| $13.4M | ﹤0.01% |
1,229,550
-230,712
|
|
||
1161
Semtech
SMTC
$7.7B
| $13.4M | ﹤0.01% |
181,864
+3,661
|
|
||
|
EVMN
1162
Evommune Inc
EVMN
$732M
| $13.4M | ﹤0.01% |
+782,121
|
|
||
1163
Corcept Therapeutics
CORT
$3.47B
| $13.4M | ﹤0.01% |
384,246
+1,186
|
|
||
1164
Pitney Bowes
PBI
$1.5B
| $13.3M | ﹤0.01% |
1,262,095
-827,252
|
|
||
1165
Immuneering
IMRX
$360M
| $13.1M | ﹤0.01% |
1,993,958
+195,176
|
|
||
1166
Fox Class B
FOX
$22.3B
| $13.1M | ﹤0.01% |
201,728
-964
|
|
||
|
TEM
1167
Tempus AI
TEM
$8.9B
| $12.9M | ﹤0.01% |
217,910
-397,804
|
|
||
|
NP
1168
Neptune Insurance Holdings
NP
$2.59B
| $12.8M | ﹤0.01% |
+440,523
|
|
||
1169
Amdocs
DOX
$7.17B
| $12.8M | ﹤0.01% |
158,444
-18,491
|
|
||
1170
Autoliv
ALV
$7.8B
| $12.7M | ﹤0.01% |
107,244
+11,213
|
|
||
1171
Euronet Worldwide
EEFT
$2.9B
| $12.7M | ﹤0.01% |
166,427
+1,570
|
|
||
1172
MoonLake Immunotherapeutics
MLTX
$1.22B
| $12.6M | ﹤0.01% |
959,553
+136,596
|
|
||
1173
Carlyle Group
CG
$16.2B
| $12.5M | ﹤0.01% |
212,114
+9,396
|
|
||
1174
Sanmina
SANM
$6.99B
| $12.5M | ﹤0.01% |
83,194
+32,352
|
|
||
1175
Gates Industrial
GTES
$5.91B
| $12.4M | ﹤0.01% |
578,749
+93,971
|
|